BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Marketing Network - ECPv5.3.1.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Marketing Network
X-ORIGINAL-URL:https://www.pharma-mkting.com
X-WR-CALDESC:Events for Pharma Marketing Network
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190430
DTEND;VALUE=DATE:20190502
DTSTAMP:20260430T023411
CREATED:20190416T213106Z
LAST-MODIFIED:20190418T143319Z
UID:14320-1556582400-1556755199@www.pharma-mkting.com
SUMMARY:Digital Health for Pharma
DESCRIPTION:This conference is the first-ever Digital Health conference built from the ground up\, specifically for pharma and life science organizations\, and we are excited to have assembled a stellar speaker line-up and agenda that covers the key ways life science organizations are leveraging digital health to drive commercial impact—from Investing to Incubating/Accelerating\, and from Commercializing to Collaborating and Co-Developing. With thought leaders from AbbVie\, Bayer\, BMS\, Boehringer Ingelheim\, Celgene\, Ferring\, GSK\, Ironwood\, MedImmune\, Novartis\, Novo Nordisk\, Pfizer\, Roche\, Sanofi\, UCB and more\, the opportunity to learn and drive change in our industry will be tremendous. \nINVEST: Equity investments in digital health companies via corporate pharma venture or innovation funds: Acquisition\, Joint Venture (i.e.\, Sanofi + Verily forming Onduo) \nINCUBATE/ACCELERATE: Internal efforts to support digital health startups (i.e.\, Novartis Biome\, Bayer Grants4Apps) or support of digital health companies via external organizations (i.e.\, Matter + Novo\, Start-up Health + Novartis) \nCOMMERCIALIZE: Typically BD&L partnerships with digital health technology organizations that leverage the life science organization’s commercialization capabilities to help bring the digital health technology to market (i.e.\, Novartis/Sandoz + Pear reSET-O) \nCOLLABORATE: Life science collaborations with digital health companies to leverage their technologies to achieve brand and customer goals (i.e.\, Boehringer Ingelheim + Propeller Health) \nCO-DEVELOP: Jointly developing a digital health solution utilizing an existing platform/asset from a digital health company and the R&D capabilities from a life science organization; typically includes governmental regulatory approval (i.e.\, Pear/Thrive + Novartis) \nWe hope you will join us at this inaugural event that we’ve designed to help accelerate our industry’s understanding of\, and ability to leverage digital health to drive commercial impact for our brands. \nReserve your seat now and be sure to use Discount Code DH19PMN for a 15% discount when signing up. \nWe look forward to seeing you at DH4P April 30–May 1 in Philly at the Sheraton Philadelphia University City!
URL:https://www.pharma-mkting.com/event/digital-health-for-pharma/
LOCATION:Sheraton Philadelphia University City\, 3549 Chestnut Street\, Philadelphia\, PA\, 19104\, United States
CATEGORIES:2019 Events,Featured Events,Marketing Conferences
ATTACH;FMTTYPE=image/png:https://www.pharma-mkting.com/wp-content/uploads/2019/04/DH19PMN_1200x627.png
ORGANIZER;CN="ExL%20Events":MAILTO:info@exlevents.com
END:VEVENT
END:VCALENDAR